Literature DB >> 24969110

ENPP2 contributes to adipose tissue expansion and insulin resistance in diet-induced obesity.

Satoshi Nishimura1, Mika Nagasaki2, Shinichi Okudaira3, Junken Aoki3, Tsukasa Ohmori4, Ryunosuke Ohkawa5, Kazuhiro Nakamura5, Koji Igarashi6, Hiroshi Yamashita7, Koji Eto8, Kansei Uno2, Naoto Hayashi9, Takashi Kadowaki10, Issei Komuro7, Yutaka Yatomi5, Ryozo Nagai4.   

Abstract

Body weight is tightly regulated by food intake and energy dissipation, and obesity is related to decreased energy expenditure (EE). Herein, we show that nucleotide pyrophosphatase/phosphodiesterase 2 (ENPP2, autotaxin) is an adipose-derived, secreted enzyme that controls adipose expansion, brown adipose tissue (BAT) function, and EE. In mice, Enpp2 was highly expressed in visceral white adipose tissue and BAT and is downregulated in hypertrophied adipocytes/adipose tissue. Enpp2(+/-) mice and adipocyte-specific Enpp2 knockout mice fed a high-fat diet showed smaller body weight gains and less insulin resistance than control mice fed the same diet. BAT was functionally more active and EE was increased in Enpp2-deficient mice. In humans, ENPP2 expression in subcutaneous fat and ENPP2 levels in serum were reduced in obese subjects. Taken together, our results establish ENPP2 as an adipose-derived, secreted enzyme that regulates adipose obesity and systemic metabolism. They also suggest ENPP2 could be a useful therapeutic target for the treatment of metabolic disease.
© 2014 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24969110     DOI: 10.2337/db13-1694

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  42 in total

Review 1.  Intestinal phospholipid and lysophospholipid metabolism in cardiometabolic disease.

Authors:  David Y Hui
Journal:  Curr Opin Lipidol       Date:  2016-10       Impact factor: 4.776

Review 2.  Lysophospholipids in coronary artery and chronic ischemic heart disease.

Authors:  Ahmed Abdel-Latif; Paula M Heron; Andrew J Morris; Susan S Smyth
Journal:  Curr Opin Lipidol       Date:  2015-10       Impact factor: 4.776

3.  The Gα12/13-coupled receptor LPA4 limits proper adipose tissue expansion and remodeling in diet-induced obesity.

Authors:  Keisuke Yanagida; Hidemitsu Igarashi; Daisuke Yasuda; Daiki Kobayashi; Takayo Ohto-Nakanishi; Noriyuki Akahoshi; Atsushi Sekiba; Tsudoi Toyoda; Tomoko Ishijima; Yuji Nakai; Nobuhiro Shojima; Naoto Kubota; Keiko Abe; Takashi Kadowaki; Satoshi Ishii; Takao Shimizu
Journal:  JCI Insight       Date:  2018-12-20

4.  Autotaxin is Related to Metabolic Dysfunction and Predicts Alzheimer's Disease Outcomes.

Authors:  Kelsey E McLimans; Auriel A Willette
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 5.  Autotaxin, a lysophospholipase D with pleomorphic effects in oncogenesis and cancer progression.

Authors:  Lorenzo Federico; Kang Jin Jeong; Christopher P Vellano; Gordon B Mills
Journal:  J Lipid Res       Date:  2015-05-14       Impact factor: 5.922

6.  Comparative Secretome Analyses of Primary Murine White and Brown Adipocytes Reveal Novel Adipokines.

Authors:  Asrar Ali Khan; Jenny Hansson; Peter Weber; Sophia Foehr; Jeroen Krijgsveld; Stephan Herzig; Marcel Scheideler
Journal:  Mol Cell Proteomics       Date:  2018-08-22       Impact factor: 5.911

7.  Effects of diet and hyperlipidemia on levels and distribution of circulating lysophosphatidic acid.

Authors:  Maria P Kraemer; Guogen Mao; Courtney Hammill; Baoxiang Yan; Yu Li; Fredrick Onono; Susan S Smyth; Andrew J Morris
Journal:  J Lipid Res       Date:  2019-09-04       Impact factor: 5.922

Review 8.  Lysophosphatidic acid signalling in development.

Authors:  Xiaoyan Sheng; Yun C Yung; Allison Chen; Jerold Chun
Journal:  Development       Date:  2015-04-15       Impact factor: 6.868

9.  Autotaxin-LPA signaling contributes to obesity-induced insulin resistance in muscle and impairs mitochondrial metabolism.

Authors:  Kenneth D'Souza; Carine Nzirorera; Andrew M Cowie; Geena P Varghese; Purvi Trivedi; Thomas O Eichmann; Dipsikha Biswas; Mohamed Touaibia; Andrew J Morris; Vassilis Aidinis; Daniel A Kane; Thomas Pulinilkunnil; Petra C Kienesberger
Journal:  J Lipid Res       Date:  2018-08-02       Impact factor: 5.922

10.  Adipose Tissue Lipokines: Recent Progress and Future Directions.

Authors:  Veronica L Li; Joon T Kim; Jonathan Z Long
Journal:  Diabetes       Date:  2020-12       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.